TY - JOUR
T1 - Expression of mDab1 promotes the stability and processing of amyloid precursor protein and this effect is counteracted by X11α
AU - Parisiadou, Loukia
AU - Efthimiopoulos, Spiros
N1 - Funding Information:
We thank Dr. Matthias Staufenbiel (Novartis Pharma, Basel, Switzerland) for providing the APP23 transgenic animals. This research was funded by the Greek General Secretariat for Research and Technology grants “PENED” and “Greek-Serbian Collaboration”, the Ministry of Education grant “Pythagoras”, the University of Athens grant “Kapodistrias”, and the European grant APOPIS (Abnormal proteins in the pathogenesis of neurodegenerative disorders—programme “life science for health”, Contract no. LSHM-CT-2003-503330).
PY - 2007/3
Y1 - 2007/3
N2 - The cytoplasmic tail of amyloid precursor protein (APP) possesses the NPTY motif to which several phosphotyrosine-binding domain-containing proteins bind, including X11α and mDab1. X11α has been shown to slow cellular APP processing and reduce secretion of Aβ peptides. However, the effect of mDab1 on APP processing has not been determined. Here, we show that mDab1 increases the levels of cellular mature APP and promotes its processing by the secretases in both transiently transfected HEK 293 cells and in neuroglioma U251 cells. These effects derive specifically from the interaction of APP with mDab1 since they are not observed in APP deletion mutants lacking the interaction module NPTY. We further demonstrate that mDab1 enhances cell surface expression of APP, possibly by interfering with its endocytosis. Interestingly, X11α and mDab1 exert opposing effects on APP processing. However, when both proteins are co-expressed the effect of X11α overrides that of mDab1. Taken together, these results suggest that the relative stoichiometry and binding affinity of the adaptor proteins determines the final outcome on APP metabolism.
AB - The cytoplasmic tail of amyloid precursor protein (APP) possesses the NPTY motif to which several phosphotyrosine-binding domain-containing proteins bind, including X11α and mDab1. X11α has been shown to slow cellular APP processing and reduce secretion of Aβ peptides. However, the effect of mDab1 on APP processing has not been determined. Here, we show that mDab1 increases the levels of cellular mature APP and promotes its processing by the secretases in both transiently transfected HEK 293 cells and in neuroglioma U251 cells. These effects derive specifically from the interaction of APP with mDab1 since they are not observed in APP deletion mutants lacking the interaction module NPTY. We further demonstrate that mDab1 enhances cell surface expression of APP, possibly by interfering with its endocytosis. Interestingly, X11α and mDab1 exert opposing effects on APP processing. However, when both proteins are co-expressed the effect of X11α overrides that of mDab1. Taken together, these results suggest that the relative stoichiometry and binding affinity of the adaptor proteins determines the final outcome on APP metabolism.
KW - Alzheimer
KW - Amyloid precursor protein
KW - Neurodegeneration
KW - Secretase
KW - X11α
KW - mDab1
UR - http://www.scopus.com/inward/record.url?scp=33846651249&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33846651249&partnerID=8YFLogxK
U2 - 10.1016/j.neurobiolaging.2005.12.015
DO - 10.1016/j.neurobiolaging.2005.12.015
M3 - Article
C2 - 16458391
AN - SCOPUS:33846651249
SN - 0197-4580
VL - 28
SP - 377
EP - 388
JO - Neurobiology of Aging
JF - Neurobiology of Aging
IS - 3
ER -